MBX Biosciences Q4 EPS $(0.49) Beats $(0.68) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.68) by 27.84 percent. This is a 4.26 percent decrease over losses of $(0.47) per share from the
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.68) by 27.84 percent. This is a 4.26 percent decrease over losses of $(0.47) per share from the same period last year.